Filter News
Area of Research
- (-) Advanced Manufacturing (1)
- (-) Neutron Science (11)
- Biology and Environment (9)
- Clean Energy (26)
- Computational Engineering (1)
- Computer Science (2)
- Fusion and Fission (3)
- Fusion Energy (1)
- Isotopes (1)
- Materials (21)
- Materials for Computing (4)
- National Security (11)
- Nuclear Science and Technology (3)
- Quantum information Science (1)
- Supercomputing (22)
News Topics
- (-) Biomedical (4)
- (-) Cybersecurity (2)
- (-) Quantum Science (4)
- (-) Transportation (2)
- 3-D Printing/Advanced Manufacturing (10)
- Artificial Intelligence (2)
- Big Data (1)
- Bioenergy (4)
- Biology (4)
- Biotechnology (1)
- Climate Change (1)
- Composites (1)
- Computer Science (7)
- Coronavirus (5)
- Decarbonization (1)
- Energy Storage (2)
- Environment (3)
- Frontier (1)
- Fusion (1)
- High-Performance Computing (1)
- Machine Learning (1)
- Materials (6)
- Materials Science (13)
- Microscopy (1)
- Nanotechnology (6)
- National Security (1)
- Neutron Science (40)
- Nuclear Energy (2)
- Physics (7)
- Security (1)
- Space Exploration (1)
- Summit (4)
- Sustainable Energy (4)
- Transformational Challenge Reactor (1)
Media Contacts
OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.
Researchers used neutrons to probe a running engine at ORNL’s Spallation Neutron Source